Stocks-RETA-Reata Pharmaceuticals Inc

RETA Reata Pharmaceuticals Inc

171.75 -0.25 (-0.14%)
Market OpenDelayed Prices By NASDAQ, in USD
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2022: Reata Pharmaceuticals Inc's revenues decreased by 80.71% and amounted to 2.22M. Net income decreased by 4.88% to -311.90M. Net assets decreased by 135.32% to -65.70M and EPS decreased from -8.19 to -8.54.
RETA's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
91.58%
Net Profit Margin
-4,130.95%
Operating Margin
-1,455.08%
Return On Investment
-58.18%